What's Hot

    IMF projects Indian economy to grow at 6.1% in 2023

    July 25, 2023

    Data | In Telangana, districts near capital have flourished, while those in periphery lag behind

    July 25, 2023

    Explained | Can the new data panel improve India’s statistics?

    July 23, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Invest PolicyInvest Policy
    Subscribe
    • Banking
    • Economy
    • Finance
    • Insurance
      • LIC
    • Investment
    • Market
    • Money
    • MF
    • More
      • Scheme
      • Property
    Invest PolicyInvest Policy
    Home TORRENT PHARMA announces Rs 20 per share interim dividend, know the stock opinion from brokerage
    Market

    TORRENT PHARMA announces Rs 20 per share interim dividend, know the stock opinion from brokerage

    InvestPolicyBy InvestPolicyFebruary 9, 2021Updated:February 28, 2021No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    TORRENT PHARMA announces Rs 20 per share interim dividend, know the stock opinion from brokerage
    Share
    Facebook Twitter LinkedIn Pinterest Email

    TORRENT PHARMA reported a year-on-year growth of 18.3 per cent in the third quarter. The company reported a profit of Rs 297 crore in the third quarter of FY 2021 as against a profit of Rs 251 crore in the same quarter last year.

    The company’s revenue has also increased in the third quarter. On an annual basis, the company’s revenue grew 1.5 per cent to Rs 1,995 crore in the third quarter from Rs 1,966 crore in the same quarter last year.

    Growth is under pressure in the US and Brazil markets and growth in domestic business remains sluggish. The company has announced an interim dividend of Rs 20 per share. Know what is the investment opinion of brokerage

    TORRENT PHARMA

    Opinion on CREDIT SUISSE TORRENT PHARMA

    CREDIT SUISSE gave an underperform rating on TORRENT PHARMA and set the target at Rs 2280. He says the sector has outperformed and margins have been strong. On the other hand, there are signs of weakness in US markets. But Indian business is expected to continue to grow better. He has said that the stock’s position in the medium term is attractive and at the same time has lowered the EPS estimate of the stock by 2 percent for FY 2021-23.

    CLSA’s opinion on TORRENT PHARMA

    CLSA has a buy rating on TORRENT PHARMA and set the target at Rs 3560.

    Opinions on TORRENT PHARMA by GOLDMAN SACHS

    GOLDMAN SACHS has Buy rating on TORRENT PHARMA and set the target at Rs 3320.

    Opinions on CITI’s TORRENT PHARMA

    CITI has given a buy rating on TORRENT PHARMA and has set a target of Rs 3100.

    Axis Brokerage City CLSA Goldman sax Jefferies Jp morgan Macquarie Motilal Osav The result Torrent Pharma
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous Article20 stocks for profit which include FREE HIT stock
    Next Article Stocks in News: These are today’s popular stocks, keep an eye on them
    InvestPolicy

      Related Posts

      Data | E-rickshaws to two-wheelers: The shift in the share of electric vehicles

      July 18, 2023

      India to push G-20 to raise MNC tax share

      July 16, 2023

      Private sector share in investment sees sharp decline in Q1

      July 14, 2023
      Add A Comment

      Leave A Reply Cancel Reply

      Top Posts

      Palm oil imports surge to seven-month high in May despite Indonesia’s ban

      June 7, 2022

      RBI measures to have positive impact on oversesas fund inflows: DEA Secretary

      July 7, 2022

      TCS Q1 Results: 5% increase in profit in June quarter, announcement of dividend of Rs 8, check record date

      July 8, 2022
      Advertisement

      Our main motto is to help our customers in making personal finance decisions easy and convenient as per their comfort. We are committed to provide accurate and unbiased information at your doorstep and keep it transparent among our customers.

      We're social. Connect with us:

      Facebook Twitter YouTube LinkedIn
      Top Insights

      IMF projects Indian economy to grow at 6.1% in 2023

      July 25, 2023

      Data | In Telangana, districts near capital have flourished, while those in periphery lag behind

      July 25, 2023

      Explained | Can the new data panel improve India’s statistics?

      July 23, 2023
      Must Read

      Search ROR-IB (meebhoomi.ap.gov.in) AP Land Records

      January 28, 2021

      LIC Kanyadan Policy 2021 | Registration Form, Eligibility and Benefits (LIC Kanyadan)

      February 6, 2021

      What are liquid assets? Why liquid assets are important for business?

      February 6, 2020
      © 2023 Invest Policy.
      • About Us
      • Contact Us
      • Advertise
      • Privacy Policy

      Type above and press Enter to search. Press Esc to cancel.